GENETIC TECHNOLOGIES LIMITED — Board/Management Information 2025

May 14, 2025

ASX Market Announcement

==> picture [93 x 59] intentionally omitted <==

Update on Board and Executive Changes

Melbourne Australia, 15 May, 2025: Genetic Technologies Limited (ASX: GTG, “Company”, “GTG”) is pleased to provide an update on Board and executive management changes.

Board Changes

Appointment of Executive Chairman and Managing Director

The Board has appointed Mr Michael Walker as the Executive Chairman and Managing Director of the Company, effective 14 May 2025.

Non-executive Director changes

The Company advises that Mr John Polinelli has resigned as a director of the Company on 14 May 2025, and that Mr William Musgrave has been appointed as the non-executive director of the Company, effective 14 May 2025.

William Musgrave, a lawyer admitted to the Supreme Court of New South Wales, brings with him 20 years of commercial experience to his role as a director at GTG. Before practicing law, he built a successful career in marketing, developing strong communications skills that ought to be a benefit to the Company. As a non-executive director, William is dedicated to fostering the Company’s growth and advancing its strategic goals.

Executive Changes

Appointment of Chief Financial Officer

The Board has appointed Jules Grove from Automic Group as the Chief Financial Officer of the Company, effective 14 May 2025.

Jules Grove is Managing Principal, CFO Advisory at Automic Group and a Chartered Accountant with a Bachelor of Commerce (Accounting). Over his career, Jules has developed a broad skill set across strategic, operational, and commercial aspects of accounting and brings strong technical experience. Jules is Big 4 trained, holding a senior position in external audit before moving to commercial roles, including executive finance and CFO roles. Jules has a particular interest in supporting growth companies by providing insight through meaningful and robust accounting and finance processes.

Appointment of Joint Company Secretary

Genetic Technologies Limited further advises that in accordance with ASX Listing Rule 3.16.1, Ms Priyamvada (Pia) Rasal from Automic Group has been appointed as the Joint Company Secretary, effective 14 May 2025.

Over 14 years Ms Pia Rasal has managed a portfolio of private companies, ASX entities and nonprofit organisations in governance, corporate secretarial and legal roles.

Mr Mark Ziirsen will continue with the Company as Company Secretary. For the purposes of ASX Listing Rule 12.6, Mr Mark Ziirsen will be the primary person responsible for communications between the Company and ASX.

- END –

Authorised for release by the Board of Directors.

For inquiries, contact: Mark Ziirsen

Company Secretary I E: mark.ziirsen@gtglabs.com

Forward Looking Statements

This announcement may contain forward-looking statements about the Company's expectations, beliefs or intentions regarding, among other things, statements regarding the expected use of proceeds. In addition, from time to time, the Company or its representatives have made or may make forward-looking statements, orally or in writing. Forwardlooking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by the Company with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of the Company's authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. As forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause the Company's actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause the Company's actual activities or results to differ materially from the activities and results anticipated in such forwardlooking statements as detailed in the Company's filings with the Securities and Exchange Commission and in its periodic filings with the ASX in Australia and the risks and risk factors included therein. In addition, the Company operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. The Company does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.